Blog
Echoing the Optimism for Medtech and Bioscience Venture Investment in the Southeast
In the final session of the 2023 Georgia Life Sciences Summit, four life science venture investors joined Radyus Research CEO Marta New to discuss best practices and errors to avoid for early stage life science companies building an “investment stack” along with their perceptions of the southeast life science innovation ecosystem and its “investability.” If…
Read MorePutting the Tech in Bio & MedTech
The convergence of life and data sciences promises to dramatically accelerate the pace of innovation and drug development. Georgia is emerging as a leader in combining these fields to address some of the most challenging problems in life sciences. While generative AI is not ready to support clinical decision making, “Intelligent call centers, appointment setting,…
Read MoreLife Science Nation bringing a medtech investor event to Atlanta in early 2024
In September, Life Science Nation announced “RESI South’ in partnership with a newly formed coalition of life science associations representing Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. The conference will come to Atlanta, GA, in [early] 2024. RESI South is expected to draw a crowd of over 500 bioscience and medtech entrepreneurs…
Read MoreJohns Creek Named First “BioReady Community” in Georgia
As the life sciences sector in Georgia continues to grow at a rapid pace, the need for bioready sites grows. As just the second state in the country to formally adopt such a program, the BioReady Community program will allow Georgia’s municipalities to showcase biotech-zoned science parks, streamline permitting, build a robust infrastructure, and identify…
Read MoreReshaping the narrative on biopharma innovation with BIO Board Chair Dr. Ted Love
Dovetailing closely on access, advocacy, policy and innovation, BIO Board Chair and founder of Global Blood Therapeutics Dr. Ted Love discussed his mission oriented journey in the life sciences in the day’s keynote. This work continues with the need to reshape the narrative around biopharma innovation, access, cost and value. “Drug cost is not a…
Read MoreAccess and Advocacy: “Share the Savings”
Americans want policymakers to see lowering out-of-pocket costs for health care as a top priority. Putting pharma and its innovators who invest billions of dollars in R&D for therapies that improve outcomes and save lives in villainous crosshairs is easy to understand and politically expedient, but misguided. In 2021, West Virginia became the first state…
Read MoreAccess and Innovation: Georgia Bio Recommits to Industry as a new c6 & New GRA CEO Opens the 2023 Georgia Life Sciences Summit
Having recently renewed our commitment to advocating for, educating and connecting our member enterprises and stakeholders, the 2023 Georgia Life Sciences Summit by Georgia Bio brought more than 300 members of the ecosystem together in Sandy Springs on November 1st. We reconnected with friends and colleagues, made new connections, learned from academic, industry and elected…
Read MoreDr. Ted W. Love: How to reframe the narrative about biotech – and put patients first
November 2, 2023 / Source BIO News Remarks from Dr. Ted W. Love, Chairman of the Biotechnology Innovation Organization (BIO) and former President and CEO of Global Blood Therapeutics, as prepared for delivery Georgia Bio’s Life Sciences Summit on November 1, 2023: Almost ten years ago, when our college-aged daughter Alex lived at home, I had a…
Read MoreDriven by Industry Demand, Georgia Bio Reemerges, Rededicates
A New Start Founded in 1989, Georgia Bio has been the entity around which the bioscience and medtech industry in the state, including academia, connects and advocates for its needs. Though recently latent in the visual presence to which stakeholders are accustomed, Georgia Bio has maintained, if not increased, its advocacy for the life science…
Read MoreICYMI: State of Georgia Bio Virtual Town Hall Recording
As many of our colleagues are now aware, Georgia Bio (and the Georgia BioEd Institute) is separating from the Center for Global Health Innovation (CGHI) and adopting a more incremental, industry-focused approach to our efforts. Georgia Bio is recommitting to its core mission of advocating for, connecting, educating and inspiring our member enterprises and stakeholders…
Read More